Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-09

Clinical Trial Update: Study of CG100649 Versus Celecoxib in Osteoarthritis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing CG100649 to celecoxib in osteoarthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CG100649 (CG100649)
  • Celecoxib (Celecoxib)

Snippet

Sponsor: CrystalGenomics, Inc. | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2023-02-09